🇪🇺 Paxlovid (Copackaged) in European Union

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EMA authorised Paxlovid (Copackaged) on 28 January 2022

Marketing authorisation

EMA — authorised 28 January 2022

Marketing authorisation holder: Pfizer Europe MA EEIG
Local brand name: Paxlovid (Copackaged)
Status: approved

Other Infectious Disease approved in European Union

Frequently asked questions

Is Paxlovid (Copackaged) approved in European Union?

Yes. EMA authorised it on 28 January 2022.

Who is the marketing authorisation holder for Paxlovid (Copackaged) in European Union?

Pfizer Europe MA EEIG holds the EU marketing authorisation.